Dr Batra's Healthcare has launched HairGain, claiming it to be India's first advanced hair regrowth treatment powered by 50 Billion Exosomes, marking a significant step in regenerative medicine and offering a non-surgical option for people struggling with hair loss.

The company said the treatment is designed to address a growing health and emotional concern affecting nearly 150 million people in India. Hair loss, once considered only a cosmetic issue, is now increasingly linked to reduced self-confidence and emotional distress. Conditions such as hereditary hair loss, post-pregnancy hair fall, menopause-related thinning and stress-induced hair loss have driven demand for treatments that promote natural hair regrowth rather than simply reducing hair fall.

HairGain has been developed for both men and women experiencing different forms of hair loss, including male and female pattern baldness, post-pregnancy hair fall, post-menopausal hair thinning, stress-related hair loss and early-stage thinning. According to the company, the treatment delivers regenerative signals directly to the scalp to activate dormant hair follicles, improve scalp health and stimulate the body's natural hair growth process.

The treatment is powered by 50 Billion Exosomes—tiny biological messengers involved in cell-to-cell communication and tissue repair. These exosomes help reactivate dormant follicles, support cellular regeneration and create a favourable environment for new hair growth.

HairGain also incorporates Dr Batra's proprietary TriXo Complex, which combines exosomes with ingredients such as PDRN (Polydeoxyribonucleotide), collagen, caffeine, growth factors, polypeptides and copper tripeptides. The formulation is designed to regenerate damaged follicles, improve blood circulation in the scalp, strengthen the scalp barrier, extend the hair growth phase and improve overall hair density and quality.

According to the company, visible improvements may be seen in around 75 days, depending on an individual's condition and treatment plan. The expected benefits include reduced hair fall, healthier scalp conditions, stronger hair roots, improved hair thickness and noticeable hair regrowth under medical supervision.

Commenting on the launch, Dr. Akshay Batra, Vice-Chairman and Managing Director of Dr Batra's Healthcare and the first Indian President of the Trichological Society of London (UK), said hair restoration is entering a new phase driven by regenerative medicine.

"Today's consumers are looking for treatments that are backed by science, minimally invasive and capable of promoting natural hair regrowth. Exosome therapy represents one of the most exciting advances in regenerative medicine because it delivers biological signals that help reactivate dormant hair follicles and support natural hair growth," he said.

Dr. Batra added that unlike platelet-rich plasma (PRP) therapy, where results may vary depending on the quality and concentration of a patient's own platelets, HairGain delivers a standardised dose of 50 Billion Exosomes, providing a more consistent regenerative effect on the scalp.

"For individuals with early to moderate hair loss, this offers a promising non-surgical option that may restore hair naturally before considering procedures such as hair transplantation," he said.

With more than four decades of experience in hair and scalp care, Dr Batra's Healthcare said it will continue investing in advanced regenerative technologies and scientific innovation to expand treatment options for patients seeking personalised, evidence-based hair restoration solutions.